9.2(top 1%)
Impact Factor
9.7(top 1%)
extended IF
363(top 1%)
citing journals
citing authors

Most Cited Articles of Oncogene

Activators and target genes of Rel/NF-kappaB transcription factors19993.3K
Cisplatin: mode of cytotoxic action and molecular basis of resistance20032.4K
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer20072.1K
MAP kinase signalling pathways in cancer20072K
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer20101.9K
STATs in oncogenesis20001.7K
The p53 pathway: positive and negative feedback loops20051.7K
Introduction to NF-kappaB: players, pathways, perspectives20061.7K
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer20031.7K
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy20061.6K
The Bcl-2 apoptotic switch in cancer development and therapy20071.6K
Molecular mechanisms of cisplatin resistance20121.6K
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer20081.5K
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo19941.5K
PI3K pathway alterations in cancer: variations on a theme20081.4K
TGF-beta and epithelial-to-mesenchymal transitions20051.3K
The tumor microenvironment and its role in promoting tumor growth20081.3K
miR-21-mediated tumor growth20071.3K
AP-1 in cell proliferation and survival20011.3K
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics20101.3K
Wnt signaling in cancer20171.2K
The Bcl-2 family: roles in cell survival and oncogenesis20031.2K
Histone deacetylase inhibitors: molecular mechanisms of action20071.2K
Mitogen-activated protein kinases in apoptosis regulation20041.2K
Autophagy as a cell death and tumor suppressor mechanism20041.2K